Treatment of HER2+/HR+early breast cancer with neratinib: final results from a retrospective single case report retrieval project

¹ Breast Center, Department of Gynecology and Obstetrics, CCC Munich, LMU University Hospital Munich, Munich, Germany

² MVZ Onkologische Kooperation Harz, Goslar, Germany

³ Practice for Gynecology and Obstetrics, Ilsede, Germany

⁴ Gynäkologische Onkologie Plauen, Plauen, Germany

⁵ General Hospital Klagenfurt am Wörthersee, Department of internal medicine and hematology and internal oncology, Klagenfurt am Wörthersee, Austria

⁶ Onkozentrum Dresden/Freiberg/Meißen, Dresden, Germany

⁷ University Hospital Ulm, Department for Gynecology and Obstetrics, Ulm, Germany

⁸ Pierre Fabre Pharma GmbH, Freiburg, Germany

⁹ Medical University of Graz, Clinical Division of Gynecology, Graz, Austria

¹⁰ University Hospital Schleswig-Holstein, Campus Kiel, Clinic for Gynecology and Obstetrics, Kiel, Germany